Literature DB >> 10682220

Familial transmission of risk factors in the first-degree relatives of schizophrenic people.

M C Waldo1, L E Adler, S Leonard, A Olincy, R G Ross, J G Harris, R Freedman.   

Abstract

Schizophrenia is a complex illness with multiple pathophysiologic factors that contribute to its psychopathology. One strategy to identify these factors is to observe them in isolation from each other, by characterizing their expression in the relatives of schizophrenic probands. By Mendel's second law, each genetic factor should be independently distributed in a sibship, so that each can be observed by itself, uncomplicated by the general problems of the illness. Such independently distributed phenotypes are obviously useful for genetic analyses; however, they can also be considered together, to model how various brain dysfunctions may combine to produce psychoses. In addition to a sensory gating deficit linked to the alpha 7-nicotinic acetylcholine receptor locus, schizophrenics and their families have a number of other deficits, including decreased hippocampal volume on magnetic resonance images and increased plasma levels of the dopamine metabolite homovanillic acid. Although such research is far from complete, a heuristic model combining a sensory gating deficit, decreased hippocampal neuron capacity, and increased dopaminergic neurotransmission is consonant with current understanding of the neuropsychology of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10682220     DOI: 10.1016/s0006-3223(99)00272-3

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  8 in total

Review 1.  Genomic copy number variation in disorders of cognitive development.

Authors:  Eric M Morrow
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-11       Impact factor: 8.829

2.  Multiple genes in the 15q13-q14 chromosomal region are associated with schizophrenia.

Authors:  Sarah H Stephens; Alexis Franks; Ralph Berger; Milda Palionyte; Tasha E Fingerlin; Brandie Wagner; Judith Logel; Ann Olincy; Randal G Ross; Robert Freedman; Sherry Leonard
Journal:  Psychiatr Genet       Date:  2012-02       Impact factor: 2.458

Review 3.  Nicotine and nicotinic system in hypoglutamatergic models of schizophrenia.

Authors:  Yousef Tizabi
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

4.  Synthesis of H-bonding probes of alpha7 nAChR agonist selectivity.

Authors:  Jingyi Wang; Roger L Papke; Nicole A Horenstein
Journal:  Bioorg Med Chem Lett       Date:  2008-11-18       Impact factor: 2.823

5.  Nicotine improves delayed recognition in schizophrenic patients.

Authors:  Carol S Myers; Olalla Robles; A Nancy Kakoyannis; Jay D Sherr; Matthew T Avila; Teresa A Blaxton; Gunvant K Thaker
Journal:  Psychopharmacology (Berl)       Date:  2004-03-02       Impact factor: 4.530

6.  Smoking, Genetics and Schizophrenia: Evidence for Self Medication.

Authors:  Sherry Leonard; Sharon Mexal; Robert Freedman
Journal:  J Dual Diagn       Date:  2007-11-01

7.  Association between the 2-bp deletion polymorphism in the duplicated version of the alpha7 nicotinic receptor gene and P50 sensory gating.

Authors:  Rachel H Flomen; Madiha Shaikh; Muriel Walshe; Katja Schulze; Mei-Hua Hall; Marco Picchioni; Fruhling Rijsdijk; Timothea Toulopoulou; Eugenia Kravariti; Robin M Murray; Philip Asherson; Andrew J Makoff; Elvira Bramon
Journal:  Eur J Hum Genet       Date:  2012-05-16       Impact factor: 4.246

8.  Neuropsychological measures of attention and memory function in schizophrenia: relationships with symptom dimensions and serum monoamine activity.

Authors:  Robert D Oades; Bernd Röpcke; Uwe Henning; Ansgard Klimke
Journal:  Behav Brain Funct       Date:  2005-08-09       Impact factor: 3.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.